The Influence of a Bupivacaine Digital Nerve Block Using Rev G.

Completed · Not applicable

Conditions studied: Patients Undergoing Spine Surgery

In brief

The investigators are proposing to continue investigation to improve the accuracy of the SpHb (continuous hemoglobin monitoring device) by administering an intermediate acting digital nerve block in the finger connected to the SpHb, specifically bupivacaine 0.25% in patients undergoing spine surgery. Bupivacaine is FDA approved and in routine use.

Key facts

Study ID

NCT01750554

Run by

University of California, San Francisco

People needed

19

Starts

2012-12-01

Expected to finish

2013-07-01

Last updated by the study team

2015-04-10

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female 18 years of age or older
• American Society of Anesthesiologists classification 1, 2 or 3
• Scheduled to undergo spine or hip surgery

You may not qualify if…

• Pregnant or nursing
• Patients who in the study investigators clinical judgement would not be suitable

Where it is running

• University of California, San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.